{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T05:14:39Z","timestamp":1783228479962,"version":"3.54.6"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Introduction: Pain is a major contributor to functional impairment in neurological patients. Botulinum toxin type A (BT-A) is well-established for focal spasticity and has shown some benefits in pain reduction. Long-term data from large cohorts remain limited. Material and Methods: This retrospective study (2017\u20132022) analyzed 20 variables from spastic patients treated with Incobotulinumtoxin A (INCO) for pain and spasticity. Functional analysis was classified into 5 major domains: Pain, Spasticity spectrum, Mobility, Activities of daily living, and Gait. Results: A total of 1575 records from 67 patients were collected. The mean age was 57.7 years, mostly female (n = 35), and stroke was the leading etiology (n = 40). The most typical patterns were wrist flexion (80%) and ankle flexion (94.9%). It was injected with 50 to 400 units of INCO, targeting an average of 3.47 upper-limb and 2.34 lower-limb muscles per session. Functional improvement was observed across all domains (GAS change 27.4), with the greatest effects in pain (GAS change 26.9; 5.16 VAS reduction). Discussion: The findings, derived from one of the largest datasets, support that INCO, and probably BT-A, should be indicated for the pain of spastic patients, regardless of etiology. Conclusions: Promising functionality outcomes, especially in this group, warrant further, more comprehensive studies.<\/jats:p>","DOI":"10.3390\/toxins18070291","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:59:47Z","timestamp":1783065587000},"page":"291","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benefits of Incobotulinumtoxin A in Pain, Spasticity and Functionality\u2014A 5 Years Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8969-2291","authenticated-orcid":false,"given":"Andr\u00e9","family":"Cruz","sequence":"first","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Unidade Local de Sa\u00fade do Alto Minho, Estrada deSanta Luzia, 4904-858 Viana do Castelo, Portugal"},{"name":"School of Medicine, University of Minho, 4710-057 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12955-015-0340-3","article-title":"The negative impact of spasticity on the health-related quality of life of stroke survivors: A longitudinal cohort study","volume":"13","author":"Gillard","year":"2015","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10790268.2018.1535638","article-title":"The impact of early spasticity on the intensive functional rehabilitation phase and community reintegration following traumatic spinal cord injury","volume":"43","author":"Nguyen","year":"2020","journal-title":"J. Spinal Cord Med."},{"key":"ref_3","unstructured":"Rivelis, Y., Zafar, N., and Morice, K. (2025, December 01). Spasticity, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507869\/."},{"key":"ref_4","first-page":"111","article-title":"Epidemiological, humanistic, and economic burden of illness of lower limb spasticity","volume":"10","author":"Martin","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijge.2018.05.005","article-title":"Post-stroke Spasticity: A Review of Epidemiology, Pathophysiology, and Treatments","volume":"12","author":"Kuo","year":"2018","journal-title":"Int. J. Gerontol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2019.05.007","article-title":"Defining the spectrum of spasticity-associated involuntary movements","volume":"65","author":"Abboud","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sc.2016.46","article-title":"Pain, spasticity and quality of life in individuals with traumatic spinal cord injury in Denmark","volume":"54","author":"Andresen","year":"2016","journal-title":"Spinal Cord"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/pm\/pnv019","article-title":"Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study","volume":"17","author":"Paolucci","year":"2016","journal-title":"Pain Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sc.2012.51","article-title":"Effects of chronic pain on quality of life and depression in patients with spinal cord injury","volume":"51","author":"Tiftik","year":"2013","journal-title":"Spinal Cord"},{"key":"ref_10","first-page":"423","article-title":"Rehabilitation procedures in the management of spasticity","volume":"46","author":"Smania","year":"2010","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/1658-354X.121087","article-title":"Spasticity\u2014Pathogenesis, prevention and treatment strategies","volume":"7","author":"Ghai","year":"2013","journal-title":"Saudi J. Anaesth."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101222","DOI":"10.1016\/j.eclinm.2021.101222","article-title":"Comparative Effectiveness of Botulinum Toxin Injections and Extracorporeal Shockwave Therapy for Post-Stroke Spasticity: A Systematic Review and Network Meta-Analysis","volume":"43","author":"Hsu","year":"2022","journal-title":"eClinicalMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PHM.0000000000002575","article-title":"Focal Shock Waves Increase Efficacy and Prolong the Effect of Botulinum Toxin on Spasticity in Patients with Brain Injury from Stroke and Multiple Sclerosis","volume":"104","author":"Saavedra","year":"2025","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1468-1331.2002.0090s1030.x","article-title":"The medical management of spasticity","volume":"9","author":"Abbruzzese","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1007\/BF00433379","article-title":"Logic, truth and language in concepts of pain","volume":"3","author":"Merskey","year":"1994","journal-title":"Qual. Life Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rashiq, S., Schopflocher, D., Taenzer, P., and Jonsson, E. (2008). History and definition of chronic pain. Chronic Pain: A Health Policy Perspective, Wiley-VCH Verlag GmbH & Co. KGaA.","DOI":"10.1002\/9783527622665"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/toxins7072454","article-title":"Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation","volume":"7","author":"Intiso","year":"2015","journal-title":"Toxins"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Park, J., and Chung, M.E. (2018). Botulinum Toxin for Central Neuropathic Pain. Toxins, 10.","DOI":"10.3390\/toxins10060224"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.apmr.2020.12.010","article-title":"Effectiveness of Botulinum Toxin A in Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-analysis","volume":"102","author":"Xie","year":"2021","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.toxicon.2021.05.012","article-title":"Analgesic effect of botulinum toxin in children with cerebral palsy: A systematic review","volume":"199","author":"Almina","year":"2021","journal-title":"Toxicon"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/pmt-2020-0015","article-title":"Botulinum toxin injections for shoulder and upper limb pain: A narrative review","volume":"10","author":"Chang","year":"2020","journal-title":"Pain Manag."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/10790268.2020.1848278","article-title":"A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury","volume":"45","author":"Lakra","year":"2022","journal-title":"J. Spinal Cord Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Egeo, G., Fofi, L., and Barbanti, P. (2020). Botulinum Neurotoxin for the Treatment of Neuropathic Pain. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00716"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Struyf, P., Triccas, L.T., Schillebeeckx, F., and Struyf, F. (2023). The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20042797"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Intiso, D., Centra, A.M., Gravina, M., Chiaramonte, A., Bartolo, M., and Di Rienzo, F. (2023). Botulinum Toxin-A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke. Toxins, 15.","DOI":"10.3390\/toxins15080509"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5535\/arm.240034","article-title":"Effects of Botulinum Toxin-A for Spasticity and Nociceptive Pain in Individuals with Spinal Cord Injury: A Systematic Review and Meta-Analysis","volume":"48","author":"Sumsuzzman","year":"2024","journal-title":"Ann. Rehabil. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Du, Y.N., Li, Y., Zhang, T.Y., Jiang, N., Wei, Y., Cheng, S.H., Li, H., and Duan, H.Y. (2024). Efficacy of botulinum toxin A combined with extracorporeal shockwave therapy in post-stroke spasticity: A systematic review. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1342545"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpainsymman.2016.01.007","article-title":"OnabotulinumtoxinA Improves Pain in Patients With Post-Stroke Spasticity: Findings From a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"52","author":"Wissel","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1161\/STROKEAHA.121.034049","article-title":"Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"52","author":"Tan","year":"2021","journal-title":"Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"de Melo Carvalho Rocha, E., Riberto, M., da Ponte Barbosa, R., Geronimo, R.M.P., and Menezes-Junior, M. (2023). Use of Botulinum Toxin as a Treatment of Hemiplegic Shoulder Pain Syndrome: A Randomized Trial. Toxins, 15.","DOI":"10.3390\/toxins15050327"},{"key":"ref_32","first-page":"12509","article-title":"Botulinum toxin in the rehabilitation of painful syndromes: Multiperspective literature analysis, lexical analysis and systematic review of randomized controlled trials","volume":"34","author":"Coraci","year":"2024","journal-title":"Eur. J. Transl. Myol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Park, J., and Park, H.J. (2017). Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins, 9.","DOI":"10.3390\/toxins9090260"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107208","DOI":"10.1016\/j.toxicon.2023.107208","article-title":"Botulinum toxin A and neuropathic pain: An update","volume":"232","author":"Spagna","year":"2023","journal-title":"Toxicon"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fonfria, E., Maignel, J., Lezmi, S., Martin, V., Splevins, A., Shubber, S., Kalinichev, M., Foster, K., Picaut, P., and Krupp, J. (2018). The Expanding Therapeutic Utility of Botulinum Neurotoxins. Toxins, 10.","DOI":"10.3390\/toxins10050208"},{"key":"ref_36","first-page":"107485","article-title":"A systematic review and meta-analysis of neutralizing antibodies after treatment with abobotulinumtoxinA, incobotulinumtoxinA and onabotulinumtoxinA across multiple indications","volume":"104","author":"Walter","year":"2025","journal-title":"Neurology"},{"key":"ref_37","first-page":"107487","article-title":"Secondary treatment failure with abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA: A systematic review and meta-analysis","volume":"104","author":"Walter","year":"2025","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e70289","DOI":"10.1111\/ene.70289","article-title":"Systematic review and meta-analysis of secondary treatment failure and immunogenicity with botulinum Neurotoxin A in Multiple Indications","volume":"32","author":"Walter","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lee, K.W.A., Chan, L.K.W., Lee, A.W.K., Lee, C.H., Wan, J., and Yi, K.-H. (2024). Immunogenicity of Botulinum Toxin Type A in Different Clinical and Cosmetic Treatment, a Literature Review. Life, 14.","DOI":"10.3390\/life14101217"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bianchi, F., Nelson, M., Wissel, J., Kim, H., Traut, A., Shah, D., Musacchio, T., and Jabbari, B. (2025). OnabotulinumtoxinA in the Management of Pain in Adult Patients with Spasticity: A Systematic Literature Review. Toxins, 17.","DOI":"10.3390\/toxins17080418"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108668","DOI":"10.1016\/j.pharmthera.2024.108668","article-title":"Neurobiological Mechanisms of Botulinum Neurotoxin-Induced Analgesia for Neuropathic Pain","volume":"259","author":"Bagues","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41598-024-54906-z","article-title":"Botulinum toxin-A effects on pain, somato sensory and psychosocial features of patients with refractory masticatory myofascial pain: A randomized double-blind clinical trial","volume":"14","author":"Poluha","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Marinelli, S., Pavone, F., and Luvisetto, S. (2025). Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain. Toxins, 17.","DOI":"10.3390\/toxins17080374"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7701940","DOI":"10.1155\/prm\/7701940","article-title":"The Use of Botulinum Toxin Injections in Peripheral Neuropathic Pain: A Systematic Review of Efficacy and Safety Outcomes","volume":"2026","author":"Restivo","year":"2026","journal-title":"Pain Res. Manag."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/291\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:15:12Z","timestamp":1783224912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070291"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070291","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}